What does optimal early detection and preventive care for breast cancer look like? As a key member of two large research consortia focused on improving cancer screening and outcomes, Diana Buist is in a prime position to help answer this important question.

Dr. Buist is an epidemiologist whose work focuses primarily on early detection of breast cancer and reducing illness and death from breast cancer in populations. She is especially interested in translating research findings into clinically meaningful guidelines. Dr. Buist joined Group Health Research Institute (GHRI) in 1996 and within a few years became the Principal Investigator of the Group Health Breast Cancer Surveillance Project, one of five sites participating in the National Cancer Institute's Breast Cancer Surveillance Consortium. She has also played a key role in several collaborative projects conducted by the HMO Cancer Research Network. Dr. Buist has extensive experience working with these diverse data and expertise in both longitudinal studies and randomized trials and interventions. So she is uniquely positioned to examine cancer screening, care, and outcomes in health systems across the country.

Dr. Buist serves on the executive committee of the American Society for Preventive Oncology and was a founding member of their Junior Members group in 1999. She is also an affiliate investigator at the Fred Hutchinson Cancer Research Center and an affiliate associate professor in the Epidemiology Department at the University of Washington. Dr. Buist enjoys sharing her expertise by mentoring junior faculty and PhD and MPH candidates and teaching courses in epidemiology internationally through the American Thoracic Society.

Related information:

• Breast Cancer Surveillance Project
• National Cancer Institute's Breast Cancer Surveillance Consortium
• HMO Cancer Research Network (CRN)
• American Society for Preventive Oncology

Top

Recent publications

Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O’Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt J, Miglioretti D On behalf of the Breast Cancer Surveillance Consortium/Cancer Intervention and Surveillance Modeling Network/Evidence-based Practice Center Collaboration Group. Risk factors for breast cancer for women age 40 to 49: a systematic review and meta-analysis. Annals Intern Med. 2012;156:635-48.

Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huan H, Heijnsdijk EAM, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, deKoning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012;156(9):609-17.

Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL. Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol. 2012;198(4):970-8. PubMed

Aiello Bowles EJ, Buist DS, Chubak J, Yu O, Johnson J, Chestnut J, Boudreau DM. Endocrine therapy initiation from 2001 through 2008 varies by age of breast cancer diagnosis and tumor size. J Oncol Pract. 2012;8(2):113-20.

Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012 Feb 25. [Epub ahead of print]. PubMed

Buist DS, Walker R, Aiello Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2012 Feb 1. [Epub ahead of print].

Zeliadt SB, Buist DS, Reid RJ, Grossman DC, Ma J, Etzioni R. Biopsy follow-up of prostate-specific antigen tests. Am J Prev Med. 2012;42(1):37-43. PubMed

Haneuse S, Buist DS, Miglioretti DL, Anderson ML, Carney PA, Onega T, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin SH, Smith RA, Sickles EA. Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology. 2012;262(1):69-79. Epub 2011 Nov 21. PubMed

Rutter CM, Johnson E, Miglioretti DL, Mandelson MT, Inadomi J, Buist DS. Adverse events after screening and follow-up colonoscopy. Cancer Causes Control. 2012 Feb;23(2):289-96. Epub 2011 Nov 22. PubMed

Rosenberg RD, Haneuse SJ, Geller BM, Buist DS, Miglioretti DL, Brenner RJ, Smith-Bindman R, Taplin SH. Timeliness of follow-up after abnormal screening mammogram: variability of facilities Radiology. 2011 Nov;261(2):404-13. Epub 2011 Sep 7.

To view more publications, please see Dr. Buist's CV.

Top

 

Site map Contact us ghc.orgJobs

Copyright Group Health Cooperative